Northern Trust’s Sionna Therapeutics SION Stock Holding History
Bought
Maintained
Sold
Other funds holding SION
Northern Trust's SION Position: Q3 2026 in Review
Northern Trust increased its Sionna Therapeutics (SION) stake by 9.3% in Q3 2026, buying an estimated $329K and bringing the position to 168,814 shares worth $888K. The position accounts for ﹤0.01% of the portfolio, ranked #3464.
Northern Trust first reported a position in SION in Q1 2025 and has held it in 7 quarters since. The position peaked at $6.8M in Q2 2026. 136 funds tracked by Wall St. Rank hold SION as of Q3 2026.
- Northern Trust held 168,814 shares of Sionna Therapeutics worth $888K as of Q3 2026.
- Northern Trust bought 14,338 Sionna Therapeutics shares in Q3 2026, an estimated $329K.
- Sionna Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #3464 holding.
- Northern Trust first reported a position in Sionna Therapeutics in Q1 2025 and has held it in 7 quarters since.
- Northern Trust's Sionna Therapeutics position peaked at $6.8M in Q2 2026.
- 136 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.